Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Pediatric Blood & Cancer|April 13, 2006
Chemotherapy for myeloid malignancy in children with Fanconi anemiaParinda A Mehta, Talia Ileri, Richard E Harris, et al.The Journal of Antimicrobial Chemotherapy|February 27, 2018
Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic studySharat Chandra, Tsuyoshi Fukuda, Kana Mizuno, et al.British Journal of Clinical Pharmacology|June 2, 2021
Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disordersSharat Chandra, Kana Mizuno, Junfang Zhao, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2019
Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?Parinda A Mehta, Chie Emoto, Tsuyoshi Fukuda, et al.Vaccine|October 19, 2017
Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi AnemiaParinda A Mehta, Sharon Sauter, Xue Zhang, et al.Clinical and Vaccine Immunology : CVI|February 6, 2015
Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi AnemiaRachel A Katzenellenbogen, Joseph J Carter, Joshua E Stern, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2016
A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant DiagnosesPooja Khandelwal, Tsuyoshi Fukuda, Kana Mizuno, et al.Pediatric Blood & Cancer|May 7, 2011
The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutationsKasiani Myers, Stella M Davies, Richard E Harris, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 16, 2010
Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic studyParinda A Mehta, Alexander A Vinks, Alexandra Filipovich, et al.British Journal of Haematology|November 28, 2008
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemiaDeepika Bhatla, Robert B Gerbing, Todd A Alonzo, et al.Pageof 9